Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics
| dc.contributor.author | Ghidelli-Disse, Sonja | en_ZA |
| dc.contributor.author | Lafuente-Monasterio, Maria | en_ZA |
| dc.contributor.author | Waterson, David | en_ZA |
| dc.contributor.author | Witty, Michael | en_ZA |
| dc.contributor.author | Younis, Yassir | en_ZA |
| dc.contributor.author | Paquet, Tanya | en_ZA |
| dc.contributor.author | Street, Leslie | en_ZA |
| dc.contributor.author | Chibale, Kelly | en_ZA |
| dc.contributor.author | Gamo-Benito, Francisco | en_ZA |
| dc.contributor.author | Bantscheff, Marcus | en_ZA |
| dc.contributor.author | Drewes, Gerard | en_ZA |
| dc.date.accessioned | 2015-11-27T09:35:20Z | |
| dc.date.available | 2015-11-27T09:35:20Z | |
| dc.date.issued | 2014 | en_ZA |
| dc.description.abstract | Most antimalarial drugs face decreased efficacy due to the emergence of resistant parasites. Therefore, the discovery of new antimalarial medicines is focused on new drugs that act by novel mechanisms and are active against different P. falciparum development stages. Screening of a focused compound library for antiparasitic activity, lead to identification of a novel class of compounds with activity against P. falciparum, 2-aminopyridines. The selected hits were validated and subjected to a lead optimization program resulting in the pre-clinical candidate MMV390048. Here we report an unbiased chemoproteomics strategy for the identification of targets of MMV390048. | en_ZA |
| dc.identifier.apacitation | Ghidelli-Disse, S., Lafuente-Monasterio, M., Waterson, D., Witty, M., Younis, Y., Paquet, T., ... Drewes, G. (2014). Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics. <i>Malaria Journal</i>, http://hdl.handle.net/11427/15411 | en_ZA |
| dc.identifier.chicagocitation | Ghidelli-Disse, Sonja, Maria Lafuente-Monasterio, David Waterson, Michael Witty, Yassir Younis, Tanya Paquet, Leslie Street, et al "Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics." <i>Malaria Journal</i> (2014) http://hdl.handle.net/11427/15411 | en_ZA |
| dc.identifier.citation | Ghidelli-Disse, S., Lafuente-Monasterio, M. J., Waterson, D., Witty, M., Younis, Y., Paquet, T., ... & Drewes, G. (2013). Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics. Malaria Journal, 13(Suppl 1), P38-P38. | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Ghidelli-Disse, Sonja AU - Lafuente-Monasterio, Maria AU - Waterson, David AU - Witty, Michael AU - Younis, Yassir AU - Paquet, Tanya AU - Street, Leslie AU - Chibale, Kelly AU - Gamo-Benito, Francisco AU - Bantscheff, Marcus AU - Drewes, Gerard AB - Most antimalarial drugs face decreased efficacy due to the emergence of resistant parasites. Therefore, the discovery of new antimalarial medicines is focused on new drugs that act by novel mechanisms and are active against different P. falciparum development stages. Screening of a focused compound library for antiparasitic activity, lead to identification of a novel class of compounds with activity against P. falciparum, 2-aminopyridines. The selected hits were validated and subjected to a lead optimization program resulting in the pre-clinical candidate MMV390048. Here we report an unbiased chemoproteomics strategy for the identification of targets of MMV390048. DA - 2014 DB - OpenUCT DO - 10.1186/1475-2875-13-S1-P38 DP - University of Cape Town J1 - Malaria Journal LK - https://open.uct.ac.za PB - University of Cape Town PY - 2014 T1 - Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics TI - Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics UR - http://hdl.handle.net/11427/15411 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/15411 | |
| dc.identifier.uri | http://dx.doi.org/10.1186/1475-2875-13-S1-P38 | |
| dc.identifier.vancouvercitation | Ghidelli-Disse S, Lafuente-Monasterio M, Waterson D, Witty M, Younis Y, Paquet T, et al. Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics. Malaria Journal. 2014; http://hdl.handle.net/11427/15411. | en_ZA |
| dc.language.iso | eng | en_ZA |
| dc.publisher | BioMed Central Ltd | en_ZA |
| dc.publisher.department | Department of Chemistry | en_ZA |
| dc.publisher.faculty | Faculty of Science | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License | en_ZA |
| dc.rights.holder | 2014 Ghidelli-Disse et al; licensee BioMed Central Ltd. | en_ZA |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0. | en_ZA |
| dc.source | Malaria Journal | en_ZA |
| dc.source.uri | http://www.malariajournal.com/ | en_ZA |
| dc.subject.other | antimalarial drugs | en_ZA |
| dc.subject.other | resistant parasites | en_ZA |
| dc.title | Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Ghidelli_Disse_Identification_of_Plasmodium_2014.pdf
- Size:
- 175.04 KB
- Format:
- Adobe Portable Document Format
- Description: